Skip to main content

Table 1 Demographic characteristics and comorbidities of patients with newly diagnosed PKD in Taiwan during 2000–2012

From: Increased risk of pulmonary and extrapulmonary tuberculosis infection in patients with polycystic kidney disease: a nationwide population-based study with propensity score-matching analysis

Variable PKD p-value
Total No Yes
N = 13,540 n = 6770 n = 6770
n n (%) / mean ± SD n (%) / mean ± SD
Gender     0.81
 Female 5660 2823 (41.7) 2837 (41.9)  
 Male 7880 3947 (58.3) 3933 (58.1)  
Age at baseline     0.99
 20–34 1164 583 (8.6) 581 (8.6)  
 35–49 3168 1580 (23.3) 1588 (23.5)  
 50–64 3903 1945 (28.7) 1958 (28.9)  
 > 65 5305 2662 (39.3) 2643 (39)  
 Age, mean(SD)   59.1 (16.8) 59.1 (16.8) 0.99
Comorbidity
 Hypertension 4509 2266 (33.5) 2243 (33.1) 0.67
 Hyperlipidemia 742 381 (5.6) 361 (5.3) 0.45
 Alcohol related disease 161 87 (1.3) 74 (1.1) 0.30
 Chronic kidney disease 2853 1427 (21.1) 1426 (21.1) 0.98
 ESRD 1437 714 (10.5) 723 (10.7) 0.80
 Chronic liver disease 885 454 (6.7) 431 (6.4) 0.42
 COPD 801 396 (5.8) 405 (6) 0.74
 Diabetes 1263 644 (9.5) 619 (9.1) 0.46
 Bacterial infection 3327 1644 (24.3) 1683 (24.9) 0.44
 Viral infection 1011 526 (7.8) 485 (7.2) 0.18
 Pneumoconiosis 171 90 (1.3) 81 (1.2) 0.49
  1. COPD chronic obstructive pulmonary disease
  2. Chi-square test, t-test